Table 3.
Outcomes after LT for HEHE
| Author | Patients, n | Criteria for LT | RR, % | RFS, % | OS rate, % |
|---|---|---|---|---|---|
| Cao et al. [50] | 2 | Unresectable, diffuse extensive hepatic bilobar lesions | 15/52 months 100/100 | ||
|
| |||||
| Brahmbhatt et al. [51] | 88 | Unresectable lesions | 1/3/5 years 88.6/78.9/77.2 | ||
|
| |||||
| Rial et al. [53] | 2 | Unresectable bilobar lesions | 5/10 years 100/100 | ||
|
| |||||
| Krasnodębski et al. [52] | 18 | Unresectable lesions | 65.9 months 100 | 1/5/15 years 94/82.6/41.3 | |
LT, liver transplantation; HEHE, hepatic epitheloid hemangioendothelioma; RR, recurrence rate; RFS, recurrence-free survival; OS, overall survival.